Skip to main content
Visit the WVU Keyser Return to Campus page for updates on WVU Keyser's fall term plans. Visit coronavirus.wvu.edu and CDC.gov for health resources related to the global COVID-19 pandemic.
  • Home
  • News
  • WVU issues statement after FDA grants full approval Pfizer COVID-19 vaccine

WVU issues statement after FDA grants full approval Pfizer COVID-19 vaccine

The following is a system-wide statement, including Potomac State College. 

West Virginia University issued the following statement on Monday (Aug. 23) after the Federal Drug Administration fully approved the Pfizer COVID-19 vaccine: 

“The University will continue its course of monitoring vaccination verification rates, infection and hospitalization rates, and other factors as we conduct sample testing, waste water testing and partner with local health departments to offer free community testing and vaccination clinics.

Our current vaccination verification rates among our faculty, staff and students are climbing - nearing or exceeding 70% on the Morgantown Campus. In some groups (ie: instructors, students in residence halls, fraternities and sororities), these rates are between 70–80%. Our data dashboard is launching this week and will help us to track progress throughout the semester.

As a result, WVU will continue to strongly encourage students, faculty and staff to be vaccinated, wear a mask in our classrooms and labs and use the proven tools available to combat the spread of COVID-19. Those on the Health Sciences Campus involved in patient care, including residents, fellows and students, are required to follow separate WVU Health System policies, including those related to COVID-19, such as masks, PPE and vaccinations.” —West Virginia University